Gastric Inhibitory Peptide (22-51) (human) (trifluoroacetate salt)

Formulation: A solid

Formal Name: L-α-glutamyl-L-lysyl-L-lysyl-L-α-glutamylglycyl-L-histidyl-L-phenylalanyl-L-seryl-L-alanyl-L-leucyl-L-prolyl-L-seryl-L-leucyl-L-prolyl-L-valylglycyl-L-seryl-L-histidyl-L-alanyl-L-lysyl-L-valyl-L-seryl-L-seryl-L-prolyl-L-glutaminyl-L-prolyl-L-arginylglycyl-L-prolyl-L-arginine, trifluoroacetate salt

Purity: ≥98%

Formula Markup: C140H226N44O41 • XCF3COOH

Formula Weight: 3181,6

Shelf life (days): 1460

Notes: Gastric inhibitory peptide (GIP) (22-51) is a pro-atherogenic 30-amino acid peptide corresponding to residues 22-51 of the GIP precursor protein proGIP that has been found in human plasma.{66525} It induces IκB-α degradation and NF-κB nuclear translocation in macrophage-differentiated THP-1 cells and isolated human aortic endothelial cells when used at a concentration of 1 µM. In vivo, GIP (22-51) increases atherosclerotic lesion area and plaque formation in ApoE-/- mice.

• SKU: CAY36968-25
• Manufacturer: Cayman Chemical
• Manufacturer SKU: 36968-25
• Green Labware: No
• Package Unit: 25 mg
• Quantity Unit: STK